Andrew Edward Ajani

机构：The Royal Melbourne Hospital · ORCID：0000-0003-3267-3456

发表论文 471 篇 · 总被引 6088 次 · h-index 38

代表论文

• Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial (2022 · The Lancet · 被引 241)
• Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial (2021 · The Lancet · 被引 158)
• Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival (2024 · European Heart Journal · 被引 39)
• Cell-free DNA as a potential biomarker for acute myocardial infarction: A systematic review and meta-analysis (2023 · IJC Heart & Vasculature · 被引 28)
• No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score (2024 · Circulation Cardiovascular Interventions · 被引 27)
• Trends in Intra-Aortic Balloon Pump Use in Cardiogenic Shock After the SHOCK-II Trial (2023 · The American Journal of Cardiology · 被引 20)